Healthcare Professionals Portal »
Choosing to take an omega-3 will provide your body the necessary nutrients for optimal tear composition and overall eye health. Choosing the right omega-3 is just as important. Omega-3’s rich in EPA and DHA in their natural triglyceride form will enhance your therapeutic outcome. PRN Physician Recommended Nutriceuticals® provides the purest, most therapeutically potent omega-3 based nutriceuticals possible. All of PRN’s omega-3 based products, when taken as recommended, deliver a therapeutic amount of omega-3 EPA and DHA as recommended by the American Heart Association.
Click here to learn more about the use of omega-3s for macular health and relief of dry eye symptoms
Omega-3 essential fatty acids are an important nutrient for growth and development throughout all stages of human life.
Over 20,000 clinical studies have shown the benefits of fish oil (i.e., marine-based omega-3 fatty acids) across a multitude of health conditions. Most North Americans, though, still suffer from harmful omega-3 deficiency resulting in between 72,000 and 96,000 preventable deaths each year.1
Click here to learn more about the benefits of omega-3s for your health and the differences between the currently available brands.
1 US National Health center for Health Statistics, 2005 data
Though many nutritional supplements including omega-3s are available, PRN Physician Recommended Nutriceuticals provides products with unmatched purity and potency, and the endorsement of the world’s leading doctors and medical thought leaders. In addition, PRN is dedicated to providing products that meet the following high standards:
Click here to learn more about the PRN difference
Simply click here to order your Dry Eye or Eye Health products
PRN Physician Recommended Nutriceuticals, a premier producer of condition-specific omega-3 products and macular vitamins, and Scope Ophthalmics, a leading distributor of innovative ophthalmic products in the UK, today announced the launch of Omega Eye in the United Kingdom and Ireland. The introduction of Omega Eye to the UK market is a significant enhancement to the treatments currently available for patients suffering from dry eye symptoms. The product offers a daily dose of 2668mg of omega-3 fatty cids in the re-esterified triglyceride form, including 1680mg of EPA and 560mg of DHA, as well as 1000 IU of Vitamin D.
With the current UK dry eye market estimated at 13MM units/annum, the market is growing at 12%/year. Experts say that this market will grow substantially in the coming years due to the aging population in the UK and also the environmental changes that can lead to dry eye symptoms.